Literature DB >> 25864020

Triage for suspected acute Pulmonary Embolism: Think before opening Pandora's Box.

David Levin1, Joon Beom Seo2, David G Kiely3, Hiroto Hatabu4, Warren Gefter5, Edwin J R van Beek6, Mark L Schiebler7.   

Abstract

This is a review of the current strengths and weaknesses of the various imaging modalities available for the diagnosis of suspected non-massive Pulmonary Embolism (PE). Without careful consideration for the clinical presentation, and the timely application of clinical decision support (CDS) methodology, the current overutilization of imaging resources for this disease will continue. For a patient with a low clinical risk profile and a negative D-dimer there is no reason to consider further workup with imaging; as the negative predictive value in this scenario is the same as imaging. While the current efficacy and effectiveness data support the continued use of Computed Tomographic angiography (CTA) as the imaging golden standard for the diagnosis of PE; this test does have the unintended consequences of radiation exposure, possible overdiagnosis and overuse. There is a persistent lack of appreciation on the part of ordering physicians for the effectiveness of the alternatives to CTA (ventilation-perfusion imaging and contrast enhanced magnetic resonance angiography) in these patients. Careful use of standardized protocols for patient triage and the application of CDS will allow for a better use of imaging resources.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomographic angiography; Magnetic resonance angiography; Nuclear medicine ventilation–perfusion scans; Patient outcomes; Pulmonary Embolism; Venous thromboembolism

Mesh:

Year:  2015        PMID: 25864020     DOI: 10.1016/j.ejrad.2015.03.023

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

Review 1.  Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.

Authors:  Scott K Nagle; Mark L Schiebler; Michael D Repplinger; Christopher J François; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  Eur J Radiol       Date:  2015-12-29       Impact factor: 3.528

2.  Magnetic Resonance Imaging of Pulmonary Embolism: Diagnostic Accuracy of Unenhanced MR and Influence in Mortality Rates.

Authors:  Lilian Pasin; Matheus Zanon; Jose Moreira; Ana Luiza Moreira; Guilherme Watte; Edson Marchiori; Bruno Hochhegger
Journal:  Lung       Date:  2017-01-23       Impact factor: 2.584

3.  Value of MRI in medicine: More than just another test?

Authors:  Edwin J R van Beek; Christiane Kuhl; Yoshimi Anzai; Patricia Desmond; Richard L Ehman; Qiyong Gong; Garry Gold; Vikas Gulani; Margaret Hall-Craggs; Tim Leiner; C C Tschoyoson Lim; James G Pipe; Scott Reeder; Caroline Reinhold; Marion Smits; Daniel K Sodickson; Clare Tempany; H Alberto Vargas; Meiyun Wang
Journal:  J Magn Reson Imaging       Date:  2018-08-25       Impact factor: 4.813

4.  Incidence of actionable findings on contrast enhanced magnetic resonance angiography ordered for pulmonary embolism evaluation.

Authors:  Mark L Schiebler; Jitesh Ahuja; Michael D Repplinger; Christopher J François; Karl K Vigen; Thomas M Grist; Azita G Hamedani; Scott B Reeder; Scott K Nagle
Journal:  Eur J Radiol       Date:  2016-05-19       Impact factor: 3.528

Review 5.  Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging.

Authors:  Nanae Tsuchiya; Edwin Jr van Beek; Yoshiharu Ohno; Hiroto Hatabu; Hans-Ulrich Kauczor; Andrew Swift; Jens Vogel-Claussen; Jürgen Biederer; James Wild; Mark O Wielpütz; Mark L Schiebler
Journal:  World J Radiol       Date:  2018-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.